ATE205205T1 - Durch hetero-aromatische ring substituierte phenyloxazolidinone als antimikrobielles mittel - Google Patents

Durch hetero-aromatische ring substituierte phenyloxazolidinone als antimikrobielles mittel

Info

Publication number: ATE205205T1
Authority: AT; Austria
Prior art keywords: optionally substituted; hetero; alkoxy; pct; substituted
Prior art date: 1995-02-03

Application number

AT96905168T

Other languages

English (en)

Inventor

Douglas K Hutchinson

Original Assignee

Upjohn Co

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1995-02-03

Filing date

1996-01-29

Publication date

2001-09-15

1996-01-29 Application filed by Upjohn Co filed Critical Upjohn Co

2001-09-15 Application granted granted Critical

2001-09-15 Publication of ATE205205T1 publication Critical patent/ATE205205T1/de

Links

NCTCGHLIHJJIBK-UHFFFAOYSA-N 3-phenyl-1,3-oxazolidin-2-one Chemical group O=C1OCCN1C1=CC=CC=C1 NCTCGHLIHJJIBK-UHFFFAOYSA-N 0.000 title abstract 2
239000004599 antimicrobial Substances 0.000 title 1
239000000460 chlorine Substances 0.000 abstract 5
229910052731 fluorine Inorganic materials 0.000 abstract 5
229910052801 chlorine Inorganic materials 0.000 abstract 4
125000004423 acyloxy group Chemical group 0.000 abstract 3
125000000217 alkyl group Chemical group 0.000 abstract 3
125000001072 heteroaryl group Chemical group 0.000 abstract 3
125000002887 hydroxy group Chemical group [H]O* 0.000 abstract 3
125000000229 (C1-C4)alkoxy group Chemical group 0.000 abstract 2
125000006552 (C3-C8) cycloalkyl group Chemical group 0.000 abstract 2
ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 abstract 2
PXGOKWXKJXAPGV-UHFFFAOYSA-N Fluorine Chemical compound FF PXGOKWXKJXAPGV-UHFFFAOYSA-N 0.000 abstract 2
125000002252 acyl group Chemical group 0.000 abstract 2
125000003545 alkoxy group Chemical group 0.000 abstract 2
239000011737 fluorine Substances 0.000 abstract 2
229910052739 hydrogen Inorganic materials 0.000 abstract 2
125000004433 nitrogen atom Chemical group N* 0.000 abstract 2
125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 abstract 2
125000004209 (C1-C8) alkyl group Chemical group 0.000 abstract 1
125000005913 (C3-C6) cycloalkyl group Chemical group 0.000 abstract 1
101100295741 Gallus gallus COR4 gene Proteins 0.000 abstract 1
125000003282 alkyl amino group Chemical group 0.000 abstract 1
230000000845 anti-microbial effect Effects 0.000 abstract 1
229910052794 bromium Inorganic materials 0.000 abstract 1
125000004663 dialkyl amino group Chemical group 0.000 abstract 1
239000001257 hydrogen Substances 0.000 abstract 1
125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 1
125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 abstract 1
-1 or O2CCH2N(CH3)2 Chemical group 0.000 abstract 1
230000000063 preceeding effect Effects 0.000 abstract 1
125000002924 primary amino group Chemical group [H]N([H])* 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/10—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing aromatic rings
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/42—Oxazoles
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Oncology (AREA)
Communicable Diseases (AREA)
Epidemiology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Plural Heterocyclic Compounds (AREA)
Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
Agricultural Chemicals And Associated Chemicals (AREA)
Saccharide Compounds (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

AT96905168T 1995-02-03 1996-01-29 Durch hetero-aromatische ring substituierte phenyloxazolidinone als antimikrobielles mittel ATE205205T1 (de)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US38427895A	1995-02-03	1995-02-03
PCT/US1996/000718 WO1996023788A1 (en)	1995-02-03	1996-01-29	Hetero-aromatic ring substituted phenyloxazolidinone antimicrobials

Publications (1)

Publication Number	Publication Date
ATE205205T1 true ATE205205T1 (de)	2001-09-15

Family

ID=23516681

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT96905168T ATE205205T1 (de)	1995-02-03	1996-01-29	Durch hetero-aromatische ring substituierte phenyloxazolidinone als antimikrobielles mittel

Country Status (19)

Country	Link
US (1)	US5910504A (de)
EP (1)	EP0807112B1 (de)
JP (1)	JPH10513446A (de)
KR (1)	KR100441334B1 (de)
CN (1)	CN1075073C (de)
AT (1)	ATE205205T1 (de)
BR (1)	BR9607017A (de)
CA (1)	CA2208603A1 (de)
CZ (1)	CZ231497A3 (de)
DE (1)	DE69615002T2 (de)
DK (1)	DK0807112T3 (de)
ES (1)	ES2163004T3 (de)
FI (1)	FI973217A7 (de)
NO (1)	NO309526B1 (de)
NZ (1)	NZ302844A (de)
PL (1)	PL185872B1 (de)
PT (1)	PT807112E (de)
RU (1)	RU2154645C2 (de)
WO (1)	WO1996023788A1 (de)

Families Citing this family (70)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
ATE205205T1 (de) *	1995-02-03	2001-09-15	Upjohn Co	Durch hetero-aromatische ring substituierte phenyloxazolidinone als antimikrobielles mittel
US6124334A (en) *	1995-02-03	2000-09-26	Pharmacia & Upjohn Company	Hetero-aromatic ring substituted phenyloxazolidinone antimicrobials
DE69631347T2 (de) *	1995-09-15	2004-10-07	Upjohn Co	Aminoaryl oxazolidinone n-oxide
GB9601666D0 (en) *	1996-01-27	1996-03-27	Zeneca Ltd	Chemical compounds
GB9702213D0 (en) *	1996-02-24	1997-03-26	Zeneca Ltd	Chemical compounds
GB9604301D0 (en) *	1996-02-29	1996-05-01	Zeneca Ltd	Chemical compounds
GB9609919D0 (en) *	1996-05-11	1996-07-17	Zeneca Ltd	Chemical compounds
DE19709443C1 (de) *	1997-03-07	1998-10-08	Clariant Gmbh	Verfahren zur Herstellung von N-Carboxyalkyl-3-fluor-4-dialkylaminoanilinen und N-Carboxymethyl-3-fluor-4-morpholinoanilin und N-Carboxyisobutyl-3-fluor-4-morpholinoanilin
DE19750968A1 (de) *	1997-03-07	1998-09-10	Clariant Gmbh	Verfahren zur Herstellung von N-Carboxyalkyl-3-fluor-4-dialkylaminoanilinen
KR20010021645A (ko) *	1997-07-11	2001-03-15	로렌스 티. 마이젠헬더	티아디아졸릴 및 옥사디아졸릴 페닐 옥사졸리디논 항균제
GB9717807D0 (en)	1997-08-22	1997-10-29	Zeneca Ltd	Chemical compounds
GB9717804D0 (en) *	1997-08-22	1997-10-29	Zeneca Ltd	Chemical compounds
GB9725244D0 (en) *	1997-11-29	1998-01-28	Zeneca Ltd	Chemical compounds
JP2002503655A (ja) *	1998-02-13	2002-02-05	ファルマシア・アンド・アップジョン・カンパニー	抗菌剤として有用な置換アミノフェニルイソオキサゾリン誘導体
JP2002504550A (ja) *	1998-02-25	2002-02-12	ファルマシア・アンド・アップジョン・カンパニー	抗微生物剤として有用な置換アミノメチルイソオキサゾリン誘導体
WO1999064417A2 (en)	1998-06-05	1999-12-16	Astrazeneca Ab	Oxazolidinone derivatives, process for their preparation and pharmaceutical compositions containing them
EP1147422A1 (de)	1999-01-27	2001-10-24	Pharmacia & Upjohn Company	Assays für modulatoren der "elongation factor p"-aktivität
US6608081B2 (en)	1999-08-12	2003-08-19	Ortho-Mcneil Pharmaceutical, Inc.	Bicyclic heterocyclic substituted phenyl oxazolidinone antibacterials, and related compositions and methods
US6297242B1 (en)	1999-08-12	2001-10-02	Ortho-Mcneil Pharmaceutical, Inc.	N-substituted amidine and guanidine oxazolidinone antibacterials and methods of use thereof
US6413981B1 (en) *	1999-08-12	2002-07-02	Ortho-Mcneil Pharamceutical, Inc.	Bicyclic heterocyclic substituted phenyl oxazolidinone antibacterials, and related compositions and methods
GB9928568D0 (en)	1999-12-03	2000-02-02	Zeneca Ltd	Chemical compounds
US6518285B2 (en)	1999-12-21	2003-02-11	Ortho Mcneil Pharmaceutical, Inc.	Piperidinyloxy and pyrrolidinyloxy oxazolidinone antibacterials
DE19962924A1 (de)	1999-12-24	2001-07-05	Bayer Ag	Substituierte Oxazolidinone und ihre Verwendung
GB0009803D0 (en) *	2000-04-25	2000-06-07	Astrazeneca Ab	Chemical compounds
PE20020300A1 (es) *	2000-08-22	2002-05-10	Pharmacia Corp	Composicion de solucion de un farmaco antibiotico a base de oxazolidinona con mejoramiento de la carga de farmaco
US6861433B2 (en) *	2000-12-15	2005-03-01	Pharmacia & Upjohn Company	Oxazolidinone photoaffinity probes
US6951863B2 (en) *	2001-02-07	2005-10-04	Ortho-Mcneil Pharmaceutical, Inc.	Pyridoarylphenly oxazolidinone antibacterials, and related compositions and methods
DE10129725A1 (de) *	2001-06-20	2003-01-02	Bayer Ag	Kombinationstherapie substituierter Oxazolidinone
AR038536A1 (es)	2002-02-25	2005-01-19	Upjohn Co	N-aril-2-oxazolidinona-5- carboxamidas y sus derivados
US7141588B2 (en)	2002-02-25	2006-11-28	Pfizer, Inc.	N-aryl-2-oxazolidinone-5-carboxamides and their derivatives
WO2003106454A1 (en) *	2002-06-12	2003-12-24	Orchid Chemicals & Pharmaceuticals Ltd	1h-isoquinoline-oxazolidinone derivaties and their use as antibacterial agents
DE60304360T2 (de)	2002-08-12	2006-11-16	Pharmacia & Upjohn Co. Llc, Kalamazoo	N-aryl-2-oxazolidinone und deren derivate
WO2004026848A1 (en) *	2002-09-20	2004-04-01	Lupin Limited	Oxazolidinone derivatives, process for their preperation and their use as antimycobacterial agents
ATE344036T1 (de)	2002-11-21	2006-11-15	Pharmacia & Upjohn Co Llc	N-(4-(piperazin-1-yl)-phenyl-2-oxazolidinon-5- carbonsäureamid-derivate und verwandte verbindungen als antibakterielle mittel
DE10300111A1 (de) *	2003-01-07	2004-07-15	Bayer Healthcare Ag	Verfahren zur Herstellung von 5-Chlor-N-({(5S)-2-oxo-3-[4-(3-oxo-4-morpholinyl)-phenyl]-1,3-oxazolidin-5-yl}-methyl)-2-thiophencarboxamid
US7304050B2 (en)	2003-09-16	2007-12-04	Pfizer Inc.	Antibacterial agents
DE10355461A1 (de)	2003-11-27	2005-06-23	Bayer Healthcare Ag	Verfahren zur Herstellung einer festen, oral applizierbaren pharmazeutischen Zusammensetzung
DE102004062475A1 (de) *	2004-12-24	2006-07-06	Bayer Healthcare Ag	Feste, oral applizierbare pharmazeutische Darreichungsformen mit modifizierter Freisetzung
EP1685841A1 (de) *	2005-01-31	2006-08-02	Bayer Health Care Aktiengesellschaft	Prophylaxe und Behandlung von thrombolischen Erkrankungen
US20060258691A1 (en) *	2005-05-13	2006-11-16	Joseph Barbosa	Methods and compositions for improving cognition
CA2619972A1 (en) *	2005-08-24	2007-03-01	Lexicon Pharmaceuticals, Inc.	Pyrrolopyridine, pyrrolopyrimidine and pyrazolopyridine compounds, compositions comprising them, and methods of their use
DE102005045518A1 (de) *	2005-09-23	2007-03-29	Bayer Healthcare Ag	2-Aminoethoxyessigsäure-Derivate und ihre Verwendung
CA2624310C (en)	2005-10-04	2014-01-07	Bayer Healthcare Ag	Polymorphic form of 5-chloro-n-({5s)-2-oxo-3-[4-(3-oxo-4-morpholinyl)-phenyl]-1,3-oxazolidin-5-yl}-methyl)-2-thiophenecarboxamide
DE102005047558A1 (de) *	2005-10-04	2008-02-07	Bayer Healthcare Ag	Kombinationstherapie substituierter Oxazolidinone zur Prophylaxe und Behandlung von cerebralen Durchblutungsstörungen
DE102005047561A1 (de)	2005-10-04	2007-04-05	Bayer Healthcare Ag	Feste, oral applizierbare pharmazeutische Darreichungsformen mit schneller Wirkstofffreisetzung
US7547421B2 (en) *	2006-10-18	2009-06-16	Ecolab Inc.	Apparatus and method for making a peroxycarboxylic acid
DE102006051625A1 (de) *	2006-11-02	2008-05-08	Bayer Materialscience Ag	Kombinationstherapie substituierter Oxazolidinone
US20100298384A1 (en) *	2006-12-04	2010-11-25	Mohamed Takhi	Novel oxazolidinone compounds as antiinfective agents
KR100872059B1 (ko)	2007-02-21	2008-12-05	주식회사 레고켐 바이오사이언스	아미독심 또는 하이드록사마이드 기를 가지는 신규한옥사졸리디논 유도체 및 이를 함유하는 의약 조성물
EP2072514A1 (de) *	2007-12-17	2009-06-24	Ferrer Internacional, S.A.	1(2)H-Tetrazol-5-yl-phenyl-oxazolidinone als antibakterielle Wirkstoffe
US8946436B2 (en)	2011-06-17	2015-02-03	Sichuan Gooddoctor Pharmaceutical Group Co., Ltd.	Oxazolidinone compounds and their uses in preparation of antibiotics
EP2602248A1 (de)	2011-12-05	2013-06-12	University Of Leicester	Neue Pyrrol Verbindungen
CN104364240B (zh) *	2012-06-08	2017-02-22	四川贝力克生物技术有限责任公司	一种用于预防或治疗分支杆菌疾病的药物
CN104873510B (zh) *	2014-02-28	2019-03-19	四川好医生药业集团有限公司	噁唑烷酮类化合物抗生物膜用途
CN103965183B (zh) *	2014-03-17	2017-05-03	上海应用技术学院	一种含氟噁唑烷酮类化合物及其制备方法和应用
CN105272976B (zh) *	2014-07-22	2018-11-20	四川好医生药业集团有限公司	一种噁唑烷酮类化合物
CN105399737B (zh) *	2014-09-10	2018-09-21	四川好医生药业集团有限公司	噁唑烷酮类化合物及其用途
HUE050317T2 (hu)	2015-05-20	2020-11-30	Amgen Inc	APJ receptor triazol agonistái
US9988369B2 (en)	2016-05-03	2018-06-05	Amgen Inc.	Heterocyclic triazole compounds as agonists of the APJ receptor
EP3541803B1 (de)	2016-11-16	2020-12-23	Amgen Inc.	Triazolpyridylverbindungen als agonisten des apj-rezeptors
US11046680B1 (en)	2016-11-16	2021-06-29	Amgen Inc.	Heteroaryl-substituted triazoles as APJ receptor agonists
US10736883B2 (en)	2016-11-16	2020-08-11	Amgen Inc.	Triazole furan compounds as agonists of the APJ receptor
WO2018093577A1 (en)	2016-11-16	2018-05-24	Amgen Inc.	Cycloalkyl substituted triazole compounds as agonists of the apj receptor
WO2018093576A1 (en)	2016-11-16	2018-05-24	Amgen Inc.	Alkyl substituted triazole compounds as agonists of the apj receptor
WO2018093579A1 (en)	2016-11-16	2018-05-24	Amgen Inc.	Triazole phenyl compounds as agonists of the apj receptor
CN106831615B (zh) *	2017-02-15	2019-02-15	南京农业大学	一类1，2，3－三唑－5－酰胺类化合物作为农用杀菌剂的应用
MA50509A (fr)	2017-11-03	2021-06-02	Amgen Inc	Agonistes de triazole fusionnés du récepteur apj
US11807624B2 (en)	2018-05-01	2023-11-07	Amgen Inc.	Substituted pyrimidinones as agonists of the APJ receptor
GB201905721D0 (en)	2019-04-24	2019-06-05	Univ Dundee	Compounds
CN113372276B (zh) *	2021-05-25	2022-04-22	三峡大学	吲唑类衍生物及其应用

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4801600A (en) *	1987-10-09	1989-01-31	E. I. Du Pont De Nemours And Company	Aminomethyl oxooxazolidinyl cycloalkylbenzene derivatives useful as antibacterial agents
US4921869A (en) *	1987-10-09	1990-05-01	E. I. Du Pont De Nemours And Company	Aminomethyl oxooxazolidinyl cycloalkylbenzene derivatives useful as antibacterial agents
CA1320730C (en) *	1987-10-16	1993-07-27	The Du Pont Merck Pharmaceutical Company	Aminomethyl oxooxazolidinyl aroylbenzene derivatives useful as antibacterial agents
ES2059467T3 (es) *	1987-10-21	1994-11-16	Du Pont Merck Pharma	Derivados de aminometil-oxooxazolidinil-etenilbenceno utiles como agentes antibacterianos.
US5254577A (en) *	1988-07-29	1993-10-19	The Du Pont Merck Pharmaceutical Company	Aminomethyloxooxazolidinyl arylbenzene derivatives useful as antibacterial agents
US4948801A (en) *	1988-07-29	1990-08-14	E. I. Du Pont De Nemours And Company	Aminomethyloxooxazolidinyl arylbenzene derivatives useful as antibacterial agents
JP2865211B2 (ja) *	1988-09-15	1999-03-08	ファルマシア・アンド・アップジョン・カンパニー	５’―インドリニル―５β―アミドメチルオキサゾリジン―２―オン類、３―（縮合環置換）フェニル―５β―アミドメチルオキサゾリジン―２―オン類および３―（窒素原子置換）フェニル―５β―アミドメチルオキサゾリジン―２―オン類
EP0610265B1 (de) *	1991-11-01	1996-12-27	PHARMACIA & UPJOHN COMPANY	Substituierte aryl- und heteroaryl-phenyloxazolidinone
SK283420B6 (sk) *	1992-05-08	2003-07-01	Pharmacia & Upjohn Company	Antimikrobiálne oxazolidinóny obsahujúce substituované diazínové skupiny
MY115155A (en) *	1993-09-09	2003-04-30	Upjohn Co	Substituted oxazine and thiazine oxazolidinone antimicrobials.
DE4332384A1 (de) *	1993-09-23	1995-03-30	Merck Patent Gmbh	Adhäsionsrezeptor-Antagonisten III
US5668286A (en) *	1994-03-15	1997-09-16	Pharmacia & Upjohn Company	Oxazolidinone derivatives and pharmaceutical compositions containing them
DE4425609A1 (de) *	1994-07-20	1996-01-25	Bayer Ag	Benzofuranyl- und Benzothienyloxazolidinone
DE4425613A1 (de) *	1994-07-20	1996-01-25	Bayer Ag	5-gliedrige Heteroaryl-oxazolidinone
ATE205205T1 (de) *	1995-02-03	2001-09-15	Upjohn Co	Durch hetero-aromatische ring substituierte phenyloxazolidinone als antimikrobielles mittel
GB9604301D0 (en) *	1996-02-29	1996-05-01	Zeneca Ltd	Chemical compounds

1996
- 1996-01-29 AT AT96905168T patent/ATE205205T1/de not_active IP Right Cessation
- 1996-01-29 US US08/875,800 patent/US5910504A/en not_active Expired - Fee Related
- 1996-01-29 NZ NZ302844A patent/NZ302844A/xx unknown
- 1996-01-29 EP EP96905168A patent/EP0807112B1/de not_active Expired - Lifetime
- 1996-01-29 RU RU97114833/04A patent/RU2154645C2/ru not_active IP Right Cessation
- 1996-01-29 PT PT96905168T patent/PT807112E/pt unknown
- 1996-01-29 DK DK96905168T patent/DK0807112T3/da active
- 1996-01-29 ES ES96905168T patent/ES2163004T3/es not_active Expired - Lifetime
- 1996-01-29 WO PCT/US1996/000718 patent/WO1996023788A1/en not_active Ceased
- 1996-01-29 PL PL96321663A patent/PL185872B1/pl not_active IP Right Cessation
- 1996-01-29 KR KR1019970705305A patent/KR100441334B1/ko not_active Expired - Fee Related
- 1996-01-29 DE DE69615002T patent/DE69615002T2/de not_active Expired - Fee Related
- 1996-01-29 BR BR9607017A patent/BR9607017A/pt not_active Application Discontinuation
- 1996-01-29 CN CN96191740A patent/CN1075073C/zh not_active Expired - Fee Related
- 1996-01-29 JP JP8523572A patent/JPH10513446A/ja not_active Withdrawn
- 1996-01-29 CA CA002208603A patent/CA2208603A1/en not_active Abandoned
- 1996-01-29 CZ CZ972314A patent/CZ231497A3/cs unknown
1997
- 1997-08-01 NO NO973550A patent/NO309526B1/no not_active IP Right Cessation
- 1997-08-04 FI FI973217A patent/FI973217A7/fi unknown

Also Published As

Publication number	Publication date
DE69615002D1 (de)	2001-10-11
NO973550L (no)	1997-10-03
US5910504A (en)	1999-06-08
NO309526B1 (no)	2001-02-12
CA2208603A1 (en)	1996-08-08
CN1172484A (zh)	1998-02-04
BR9607017A (pt)	1997-10-28
NO973550D0 (no)	1997-08-01
CN1075073C (zh)	2001-11-21
KR100441334B1 (ko)	2004-10-20
DK0807112T3 (da)	2001-12-17
EP0807112B1 (de)	2001-09-05
PL185872B1 (pl)	2003-08-29
HK1008898A1 (en)	1999-07-23
EP0807112A1 (de)	1997-11-19
JPH10513446A (ja)	1998-12-22
WO1996023788A1 (en)	1996-08-08
AU703465B2 (en)	1999-03-25
CZ231497A3 (cs)	1998-08-12
DE69615002T2 (de)	2002-06-13
RU2154645C2 (ru)	2000-08-20
AU4899896A (en)	1996-08-21
PT807112E (pt)	2002-02-28
ES2163004T3 (es)	2002-01-16
PL321663A1 (en)	1997-12-22
FI973217A0 (fi)	1997-08-04
FI973217A7 (fi)	1997-08-04
NZ302844A (en)	1999-06-29
KR19980701908A (ko)	1998-06-25

Legal Events

Date	Code	Title	Description
2001-11-15	UEP	Publication of translation of european patent specification
2006-10-15	REN	Ceased due to non-payment of the annual fee

Publication	Publication Date	Title
ATE205205T1 (de)	2001-09-15	Durch hetero-aromatische ring substituierte phenyloxazolidinone als antimikrobielles mittel
DE69325454D1 (de)	1999-07-29	Taxol-derivate
UA41290C2 (uk)	2001-09-17	Гетероариламіни, фармацевтична композиція, спосіб інгібування холінестерази у ссавців, спосіб покращення пам'яті
ES2185054T3 (es)	2003-04-16	Derivados de benzopirano.
ES2143526T3 (es)	2000-05-16	Derivados de amida que tienen actividad antihipercolesterolemica, su preparacion y sus usos terapeuticos.
DE69728544D1 (de)	2004-05-13	Totalsynthese von acylfulvenen mit antitumorwirkung
ATE319680T1 (de)	2006-03-15	Substituierte 2-benzylamino-2-phenyl- acetamidverbindungen
GR3029471T3 (en)	1999-05-28	2-substituted quinolines for treating leishmanioses.
FI953784A0 (fi)	1995-08-09	3'-atsiridinoantrasykliinijohdannaiset
NO955234L (no)	1996-02-21	Isokinolinderivater som terapautiske midler
ECSP941050A (es)	1994-11-16	Derivados de benzofurano, proceso para su preparacion y composicion farmaceutica que los contiene
PE20000734A1 (es)	2000-08-18	Compuestos heterociclicos derivados de furopiridina y su uso terapeutico
ES2190781T3 (es)	2003-08-16	Derivados de 1-trifluorometil-4-hidroxi-7-piperidinil-aminometilcromano.
TW354780B (en)	1999-03-21	2-disubstituted cyclohexenyl and cyclohexyl antimicrobial agents
AR001767A1 (es)	1997-12-10	Derivados de ciclolignanos utiles como inmunosupresores composiciones farmaceuticas que los contienen y procedimiento para preparar dichos derivados
TR199701289T2 (xx)	1998-08-21	Karbapenemlerin esterleri
ES2140393T3 (es)	2000-03-01	Compuestos de penem.
ECSP951529A (es)	1997-05-16	Compuestos farmaceuticos
ECSP972170A (es)	1998-12-14	Compuestos para el tratamiento de infecciones bacterianas